Abiopharma

🔍 Farr Meryl Kennedy (Director)

Company: Origin Bancorp, Inc. (OBK)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 407 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,205.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | shares_owned_after: 7,663.00
• Sold 407 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 813.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3, F3, F2

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: The reported shares are held by the reporting person's spouse and were acquired pursuant to restricted stock unit awards and purchases under employee stock purchase plan in connection with the spouse's employment with Forth Insurance, a subsidiary of the issuer.
• F3: Granted on August 20, 2025, vesting ratably over three years with the first vest date of August 20, 2026.